Use of the neutrophil-to-lymphocyte ratio and an oxygen requirement to predict disease severity in patients with COVID-19
暂无分享,去创建一个
S. Miyano | S. Imoto | S. Ogawa | H. Namkoong | M. Ishii | N. Harada | T. Yoshiyama | Y. Mutoh | Yasushi Nakano | T. Ishiguro | T. Asakura | H. Kamata | Akinori Kimura | Kensuke Nakagawara | S. Chubachi | Shiro Otake | K. Lee | K. Arimura | Takahiro Fukushima | R. Edahiro | N. Hasegawa | S. Ueda | Hiromu Tanaka | K. Fukunaga | Yusuke Suzuki | Fukuki Saito | Y. Kitagawa | T. Ozawa | K. Murakami | Mayuko Watase | Tetsuya Ueda | R. Koike | K. Tokunaga | T. Kanai | Yukinori Okada | Katunori Masaki
[1] Y. Okada,et al. Clinical significance of prediabetes, undiagnosed diabetes and diagnosed diabetes on critical outcomes in COVID‐19: Integrative analysis from the Japan COVID‐19 task force , 2022, Diabetes, obesity & metabolism.
[2] Y. Okada,et al. Clinical Characteristics of Patients with Coronavirus Disease (COVID-19): Preliminary Baseline Report of Japan COVID-19 Task Force, a Nationwide Consortium to Investigate Host Genetics of COVID-19 , 2021, International Journal of Infectious Diseases.
[3] M. Kanai,et al. Japan COVID-19 Task Force: a nation-wide consortium to elucidate host genetics of COVID-19 pandemic in Japan , 2021, medRxiv.
[4] Yibin Wang,et al. The Neutrophil-to-Lymphocyte Ratio Determines Clinical Efficacy of Corticosteroid Therapy in Patients with COVID-19 , 2021, Cell Metabolism.
[5] J. Fogel,et al. Outcomes in Patients With COVID-19 Disease and High Oxygen Requirements , 2021, Journal of clinical medicine research.
[6] J. Calvin,et al. Neutrophil-to-lymphocyte ratio on admission to predict the severity and mortality of COVID-19 patients: A meta-analysis , 2020, The American Journal of Emergency Medicine.
[7] M. Antonelli,et al. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy. , 2020, JAMA internal medicine.
[8] S. Nirenberg,et al. Vital signs assessed in initial clinical encounters predict COVID-19 mortality in an NYC hospital system , 2020, Scientific Reports.
[9] K. Kerboua. NLR: A Cost-effective Nomogram to Guide Therapeutic Interventions in COVID-19 , 2020, Immunological investigations.
[10] Theodora Psaltopoulou,et al. Hematological findings and complications of COVID‐19 , 2020, American journal of hematology.
[11] Yan Zhao,et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19 , 2020, Journal of Infection.
[12] Taiwen Li,et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa , 2020, International Journal of Oral Science.
[13] Ting Yu,et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study , 2020, The Lancet Respiratory Medicine.
[14] Taiwen Li,et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa , 2020, International Journal of Oral Science.
[15] Jiann-Jou Yang,et al. IL-19 Induces Production of IL-6 and TNF-α and Results in Cell Apoptosis Through TNF-α1 , 2002, The Journal of Immunology.